118 - What are Drug/Device Master Files and When to Use for Combination Product Submissions? with Doug Mead
Doug Mead, founder of CP Pathways, explains the regulatory differences between Drug Master Files (DMFs) and Device Master Files (MAFs) for combination products. He details the five types of DMFs and contrasts them with the less formal MAFs, noting that CDRH and CDER often lack cross-access to each other's files. Mead argues that for finished devices or platforms, it is often more efficient to include device content directly in Module 3.2.R of an NDA or BLA rather than maintaining a separate MAF. He highlights challenges such as supplier reluctance to grant Letters of Authorization and the redundancy of updating both a master file and a supplement.